The role of serum B cell activation factor in the diagnosis and phenotypes of chronic rhinosinusitis with nasal polyps
-
摘要: 目的 探讨慢性鼻窦炎伴鼻息肉(CRSwNP)患者血清B细胞活化因子(BAFF)水平变化及在息肉组织分型中的应用价值。方法 选取40例健康志愿者(对照组)和77例CRSwNP患者作为研究对象, 并根据术后组织病理切片中嗜酸粒细胞浸润比例将CRSwNP分为非嗜酸性CRSwNP组(neCRSwNP组, n=40)和嗜酸性CRSwNP组(eCRSwNP组, n=37)。收集所有被纳入者的血清, 通过ELISA检测血清BAFF水平, 并探讨其与患者临床指标的联系。通过受试者工作曲线(ROC)和多因素Logistic回归评估血清BAFF在eCRSwNP判定中的应用价值。结果 CRSwNP组患者血清BAFF浓度为(1.2±0.4) ng/mL, 高于对照组的(0.8±0.3) ng/mL, 此外, eCRSwNP组血清BAFF浓度为(1.3±0.5) ng/mL, 高于neCRSwNP组的(1.1±0.2) ng/mL, 且两组均高于对照组水平, 差异均有统计学意义(P < 0.05)。CRSwNP患者血清BAFF浓度与组织嗜酸粒细胞浸润比例(r=0.629, P < 0.001)和数量(r=0.563, P < 0.001)、外周血嗜酸粒细胞比例(r=0.411, P=0.002)和数量(r=0.501, P < 0.001)以及血清总IgE均呈正相关(r=0.178, P=0.021)。多因素Logistic回归显示血清BAFF浓度是CRSwNP分型的相关因素(OR=3.652, P=0.001)。ROC分析结果显示, 血清BAFF浓度对eCRSwNP的判定具有较好的预测价值(AUC=0.885),结论 CRSwNP患者血清BAFF浓度升高且与组织嗜酸性炎症程度相关, 术前检测血清BAFF水平可能有助于早期判定CRSwNP组织亚型。Abstract: Objective To investigate the changes of serum B cell activating factor(BAFF) levels in chronic rhinosinusitis with nasal polyps(CRSwNP) patients and its predictive value in phenotypes.Methods Forty healthy volunteers(control group) and 77 patients with CRSwNP were recruited in the present study, all CRSwNP patients were divided into eosinophilic(neCRSwNP group, n=40) and non-eosinophilic(eCRSwNP group, n=37) according to the degree of eosinophil infiltration in postoperative histological sections. Serum samples were collected from all subjects, and serum BAFF levels were detected by ELISA, and the relationships between BAFF levels and clinical variables were evaluated. The predictive value of serum BAFF in distinguishing eCRSwNP was evaluated by receiver operating curve(ROC) and Logistic regression.Results BAFF concentrations in the serum of CRSwNP patients were(1.2±0.4) ng/mL, which were higher than control group([0.8±0.3]ng/mL). In addition, serum BAFF levels in eCRSwNP group were (1.3±0.5) ng/mL, which were higher than neCRSwNP group([1.1±0.2]ng/mL), and both groups were higher than control groupt(P < 0.05). The elevated serum BAFF levels in CRSwNP patients were positively correlated with the tissue eosinophil percentage(r=0.629, P < 0.001) and counts(r=0.563, P < 0.001), peripheral blood eosinophil percentage(r=0.411, P=0.002) and counts(r=0.501, P < 0.001), and serum total IgE(r=0.178, P=0.021). Multivariate Logistic regression showed that serum BAFF level was an independent factor associated with CRSwNP phenotypes(OR=3.652, P=0.001). ROC analysis suggested that serum BAFF exhibited a good predictive value for eCRSwNP(AUC=0.885).Conclusion Serum BAFF levels were increased in CRSwNP patients and associated with the degree of systemic and polyp eosinophilic inflammation. Preoperative evaluation of serum BAFF level maybe clinically meaningful for distinguishing CRSwNP phenotypes.
-
Key words:
- sinusitis /
- nasal polyps /
- B cell activating factor /
- eosinophil
-
表 1 三组研究对象的临床资料比较
临床指标 对照组 neCRSwNP组 eCRSwNP组 P 例数 40 40 37 年龄/岁 39.0(29.0, 46.0) 41.0(32.0, 52.0) 43.0(35.0, 54.0) 0.358 男/女 23/17 25/15 21/16 0.854 变应性鼻炎/例(%) 0(0) 3(7.5) 7(18.9) 0.012 哮喘/例(%) 0(0) 3(7.5) 9(24.3) 0.002 外周血嗜酸粒细胞数量/(×106·L-1) 109.6(69.8, 193.3) 187.8(109.1, 266.7) 284.2(187.5, 368.0) 0.001 外周血嗜酸粒细胞比例/% 1.7(1.1, 2.5) 2.3(1.5, 2.8) 3.8(2.4, 5.0) 0.001 血清总IgE浓度/(IU·mL-1) - 74.0(42.1, 102.7) 133.2(79.8, 175.2) 0.001 病程/年 - 4.0(2.0, 5.0) 4.0(3.0, 5.0) 0.816 VAS评分 - 6.0(4.0, 8.0) 5.0(4.0, 7.0) 0.798 Lund-Mackay评分 - 18.0(13.0, 21.0) 19.0(14.0, 22.0) 0.519 Lund-Kennedy评分 - 9.0(7.0, 12.0) 9.0(7.0, 11.0) 0.902 表 2 与CRSwNP组织分型相关临床变量的多因素Logistic回归分析
临床变量 OR 95%CI P 变应性鼻炎 1.736 0.917~2.936 0.231 哮喘 2.469 0.938~4.032 0.086 外周血嗜酸粒细胞数量 1.989 1.145~3.077 0.036 外周血嗜酸粒细胞比例 2.415 1.327~3.698 0.010 血清总IgE浓度 1.386 1.084~2.358 0.049 血清BAFF浓度 3.652 1.732~5.944 0.001 表 3 ROC曲线分析探讨诊断指标的诊断价值
诊断指标 AUC 95%CI P 临界值 灵敏度 特异度 外周血嗜酸粒细胞数/(×106·L-1) 0.669 0.549~0.789 0.003 208.5 0.811 0.570 外周血嗜酸粒细胞比例/% 0.747 0.639~0.855 0.001 2.8 0.919 0.474 血清总IgE浓度/(IU·mL-1) 0.536 0.417~0.663 0.432 123.5 0.405 0.825 血清BAFF浓度/(ng·mL-1) 0.885 0.828~0.963 0.001 1.1 0.973 0.725 -
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi: 10.3760/cma.j.issn.1673-0860.2019.02.001
[2] 彭敏, 张丹梅, 刘璐璐, 等. 慢性鼻窦炎伴鼻息肉患者无症状气道高反应的预测因素[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(4): 345-350. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202104014.htm
[3] 杜艳玲, 孔慧, 于博, 等. 改良鼻内镜评分及ELR值与慢性鼻窦炎伴鼻息肉亚分型的相关性分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(4): 306-310. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202004005.htm
[4] 杨凤娟, 甘卫刚, 刘锋, 等. 鼻腔菌群多样性与慢性鼻窦炎伴鼻息肉手术预后相关性分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(9): 799-804. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202009008.htm
[5] 朱梦迪, 高学欢, 朱壮, 等. 鼻呼出气一氧化氮测定在慢性鼻窦炎伴鼻息肉诊断及分型中的应用价值[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(3): 216-223. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202103006.htm
[6] Park JK, Lee YJ, Bitoun S, et al. Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2019, 78(2): 282-284. doi: 10.1136/annrheumdis-2018-214025
[7] 孙雪芳, 夏立军. BAFF在嗜酸粒细胞及中性粒细胞为主型的伴有鼻息肉的慢性鼻窦炎中发病机制的相关研究[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(2): 183-186. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201902023.htm
[8] Quan R, Chen C, Yan W, et al. BAFF Blockade Attenuates Inflammatory Responses and Intestinal Barrier Dysfunction in a Murine Endotoxemia Model[J]. Front Immunol, 2020, 11: 570920. doi: 10.3389/fimmu.2020.570920
[9] Matsushita T, Kobayashi T, Kano M, et al. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease[J]. J Dermatol, 2019, 46(12): 1190-1196. doi: 10.1111/1346-8138.15117
[10] Dilidaer, Zheng Y, Liu Z, et al. Increased BAFF expression in nasal polyps is associated with local IgE production, Th2 response and concomitant asthma [J]. Eur Arch Otorhinolaryngol, 2017, 274(4): 1883-1890. doi: 10.1007/s00405-016-4435-1
[11] Li Y, Wang W, Ying S, et al. A Potential Role of Group 2 Innate Lymphoid Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps[J]. Allergy Asthma Immunol Res, 2021, 13(3): 363-374. doi: 10.4168/aair.2021.13.3.363
[12] Eslami M, Meinl E, Eibel H, et al. BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid[J]. Front Cell Dev Biol, 2020, 8: 577662. doi: 10.3389/fcell.2020.577662
[13] Alturaiki W. The roles of B cell activation factor(BAFF)and a proliferation-inducing ligand(APRIL)in allergic asthma[J]. Immunol Lett, 2020, 225: 25-30. doi: 10.1016/j.imlet.2020.06.001
[14] Andreou NP, Legaki E, Dovrolis N, et al. B-cell activating factor(BAFF)expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment[J]. Dig Liver Dis, 2021, 53(5): 574-580. doi: 10.1016/j.dld.2020.11.030
[15] Cheng CW, Tang KT, Fang WF, et al. Synchronized expressions of serum osteopontin and B cell-activating factor in autoimmune thyroid disease[J]. Eur J Clin Invest, 2019, 49(7): e13122.
[16] Wang XZ, Wan Z, Xue WJ, et al. B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study[J]. Front Immunol, 2019, 10: 1046. doi: 10.3389/fimmu.2019.01046